Increasing pressure on healthcare systems highlight the need for new innovative approaches to disease prevention and treatment. We are developing new technologies to enable shorter development cycles and large scale manufacturability and increase the accessibility, affordability, durability, specificity, safety and effectiveness of immunotherapies for millions of patients worldwide.